CTLA4 gene polymorphisms and multiple sclerosis in Northern Ireland.
J Neuroimmunol
; 187(1-2): 187-91, 2007 Jul.
Article
en En
| MEDLINE
| ID: mdl-17524498
Four CTLA4 polymorphisms were investigated in a Northern Irish collection of relapsing-remitting (RR) and primary-progressive (PP) multiple sclerosis (MS) patients. The CTLA4 promoter (-318 C/T), exon 1 (+49 A/G) and intergenic CT60 SNPs, as well as a microsatellite found in the 3' UTR (AT(n)) were analysed in 246 RRMS, 84 PPMS and 158 healthy controls. The A allele of the exon 1 +49 A/G SNP (OR=1.36; 95% CI=1.11-1.81; P=0.038), and more so the AA genotype (OR=1.70; 95% CI=1.11-2.60; P=0.015) were associated with RR, but not PPMS. In the PPMS population, overall allele distribution of the AT(n) microsatellite was significantly different from that in the healthy controls. We did not find any association with the promoter (-318 C/T) or intergenic CT60 SNPs in either of the disease cohorts. In concordance with several recent studies, we detected a trend toward higher carriage rates of the +49 G allele in PP vs RR MS patients (66.7% vs 58.9%), though this was not significant. Our data highlight the CTLA4 +49 A/G and 3'UTR polymorphisms as potential modifiers of disease course in MS.
Buscar en Google
Colección:
01-internacional
Base de datos:
MEDLINE
Asunto principal:
Polimorfismo Genético
/
Antígenos de Diferenciación
/
Antígenos CD
/
Predisposición Genética a la Enfermedad
/
Esclerosis Múltiple
Tipo de estudio:
Etiology_studies
Límite:
Humans
País/Región como asunto:
Europa
Idioma:
En
Revista:
J Neuroimmunol
Año:
2007
Tipo del documento:
Article
Pais de publicación:
Países Bajos